Oesophagostomum medical therapy: Difference between revisions
Hardik Patel (talk | contribs) No edit summary |
m Changes made per Mahshid's request |
||
| (One intermediate revision by one other user not shown) | |||
| Line 4: | Line 4: | ||
==Medical Therapy== | ==Medical Therapy== | ||
The typical adult therapy for oesophagostomiasis is a single 400 mg dose of [[albendazole]] (200 mg for children) or [[pyrantel pamoate]].<ref>“GIDEON Infectious Diseases - Diseases.” GIDEON Infectious Disease Database. 5 Feb 2009. <http://web.gideononline.com/web/epidemiology/index.php?gdn_form=ZGlzZWFzZT0xMTY1MA==>.</ref> Albendazole works by binding to the free beta tubulin, which inhibits tubulin polymerization. This results in the inhibition of glucose uptake by the Oesophagostomum. Albendazole and pyrantel pamoate at these doses have cure rates of 85% and 59-82%, respectively. | The typical adult therapy for oesophagostomiasis is a single 400 mg dose of [[albendazole]] (200 mg for children) or [[pyrantel pamoate]].<ref>“GIDEON Infectious Diseases - Diseases.” GIDEON Infectious Disease Database. 5 Feb 2009. <http://web.gideononline.com/web/epidemiology/index.php?gdn_form=ZGlzZWFzZT0xMTY1MA==>.</ref> Albendazole works by binding to the free beta tubulin, which inhibits tubulin polymerization. This results in the inhibition of glucose uptake by the Oesophagostomum. Albendazole and pyrantel pamoate at these doses have cure rates of 85% and 59-82%, respectively. Excision of ''Oesophagostomum'' larvae from nodules has been shown to have a curative effect on the patient but is invasive and more resource intensive than chemotherapy. | ||
For oesophagostomiasis with complications, the type of treatment varies depending on the severity of the disease. Usually 200–400 mg of [[albendazole]] will be given immediately and continued for up to 5 days in conjunction with 250 mg dosages of [[amoxicillin]].<ref>Ziem, J.B. “Controlling human oesophagostomiasis in northern Ghana.” (Doctoral thesis) Leiden University. 2006. <https://openaccess.leidenuniv.nl/dspace/handle/1887/4917?mode=more>.</ref> | For oesophagostomiasis with complications, the type of treatment varies depending on the severity of the disease. Usually 200–400 mg of [[albendazole]] will be given immediately and continued for up to 5 days in conjunction with 250 mg dosages of [[amoxicillin]].<ref>Ziem, J.B. “Controlling human oesophagostomiasis in northern Ghana.” (Doctoral thesis) Leiden University. 2006. <https://openaccess.leidenuniv.nl/dspace/handle/1887/4917?mode=more>.</ref> | ||
| Line 13: | Line 13: | ||
[[Category:Needs overview]] | [[Category:Needs overview]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Nematodes]] | [[Category:Nematodes]] | ||
[[Category:Zoonoses]] | [[Category:Zoonoses]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Latest revision as of 18:31, 18 September 2017
|
Oesophagostomum Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Oesophagostomum medical therapy On the Web |
|
American Roentgen Ray Society Images of Oesophagostomum medical therapy |
|
Risk calculators and risk factors for Oesophagostomum medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Medical Therapy
The typical adult therapy for oesophagostomiasis is a single 400 mg dose of albendazole (200 mg for children) or pyrantel pamoate.[1] Albendazole works by binding to the free beta tubulin, which inhibits tubulin polymerization. This results in the inhibition of glucose uptake by the Oesophagostomum. Albendazole and pyrantel pamoate at these doses have cure rates of 85% and 59-82%, respectively. Excision of Oesophagostomum larvae from nodules has been shown to have a curative effect on the patient but is invasive and more resource intensive than chemotherapy.
For oesophagostomiasis with complications, the type of treatment varies depending on the severity of the disease. Usually 200–400 mg of albendazole will be given immediately and continued for up to 5 days in conjunction with 250 mg dosages of amoxicillin.[2]
References
- ↑ “GIDEON Infectious Diseases - Diseases.” GIDEON Infectious Disease Database. 5 Feb 2009. <http://web.gideononline.com/web/epidemiology/index.php?gdn_form=ZGlzZWFzZT0xMTY1MA==>.
- ↑ Ziem, J.B. “Controlling human oesophagostomiasis in northern Ghana.” (Doctoral thesis) Leiden University. 2006. <https://openaccess.leidenuniv.nl/dspace/handle/1887/4917?mode=more>.